Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled time : 14:30 save search
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published: 2024-03-11 (Crawled : 14:30) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.0%
H: 2.38%
C: 1.12%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
fda drug wegovy approved
Decision Tracker: FDA Decisions: Amgen’s Bone-Preserving Blockbuster Picks Up Two New Challengers
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: -0.15%
H: 3.43%
C: 3.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
fda
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 1.56%
H: 3.55%
C: 0.81%
precision approval arcus program trial
EPOW's “High-Energy Fast Charging Lithium Battery Graphite Anode Project” Secures Approval in Industrialization of Advanced Scientific and Technological Achievements
Published: 2024-03-04 (Crawled : 14:30) - globenewswire.com
EPOW | News | $0.816 -4.4% 1.5K
|
Administrative and Support and ...
|
| O: 1.05%
H: 6.86%
C: -1.16%
charging lithium approval battery advanced
FDA Decisions: J&J’s Rybrevant Becomes First Front-Line Treatment for Type of NSCLC
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.65%
H: 1.13%
C: -1.02%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
fda first treatment rybrevant
UATP Receives Patent Approval for Innovative New Payment Technology
Published: 2024-02-15 (Crawled : 14:30) - prnewswire.com
DAL | $47.85 -0.06% -0.02% 12M
|
Transportation
|
| O: 0.86%
H: 0.56%
C: -0.46%
AAL | $14.03 1.01% 1.0% 35M
|
Transportation
|
| O: 1.08%
H: 0.83%
C: -0.8%
patent approval payment technology
Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
SGMO | $0.4853 -5.95% -6.33% 1.7M
|
Health Technology
|
| O: 8.46%
H: 35.96%
C: 29.21%
st-920 fda disease approval prime ema therapeutics potential
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria PanelIncreases number of bacteria species detected with addition of Acinetobacter baumannii
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
TTOO A | $2.97 1.02% 1.01% 110K
|
Health Technology
|
| O: 27.61%
H: 11.38%
C: 4.01%
fda bacteria biosystems clearance
Johnson &Johnson's nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)
Published: 2024-02-09 (Crawled : 14:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
fda disease granted treatment risk designation therapy
BOLLINGER MOTORS RECEIVES IRS APPROVAL FOR $40,000 COMMERCIAL EV FEDERAL TAX CREDIT
Published: 2024-02-06 (Crawled : 14:30) - prnewswire.com
MULN | $2.9 0.69% 0.69% 680K
|
Information
|
| O: 3.8%
H: 6.61%
C: -2.95%
approval commercial
Mullen Announces Bollinger Motors Receives IRS Approval for $40,000 Commercial EV Tax Credit
Published: 2024-02-06 (Crawled : 14:30) - globenewswire.com
MULN | $2.9 0.69% 0.69% 680K
|
Information
|
| O: 3.8%
H: 6.61%
C: -2.95%
approval commercial
SEP Acquisition Shareholders Approve SANUWAVE Deal
Published: 2024-01-31 (Crawled : 14:30) - spacfeed.com
FIAC | $11.04 0.09% 8.6K
|
n/a
| Email alert
Add to watchlist
TENK | $11.12 5.06% 260
|
n/a
| Email alert
Add to watchlist
sanuwave acquisition deal
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
VNDA | News | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: 1.37%
H: 1.35%
C: -2.7%
vtr-297 fda drug candidate approval treatment pharmaceuticals antifungal
Deep Medicine Shareholders Approve TruGolf Merger
Published: 2024-01-26 (Crawled : 14:30) - spacfeed.com
NVVE | $0.664 0.56% 0.56% 91K
|
Manufacturing
|
| O: -19.68%
H: 3.88%
C: -20.5%
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
Published: 2024-01-23 (Crawled : 14:30) - globenewswire.com
AGRX | $0.6022 0.0% 3M
|
Health Technology
|
| O: 0.0%
H: 5.41%
C: -2.03%
contraceptives
FDA Decisions: J&J's Bladder Cancer Drug Wins Full Approval
Published: 2024-01-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.36%
H: 2.11%
C: 1.29%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
fda drug approval bladder cancer
Newcourt Shareholders Approve Psyence Bioscience Deal
Published: 2024-01-19 (Crawled : 14:30) - spacfeed.com
PB A | $59.69 0.51% 0.0% 400K
|
Finance
|
| O: 0.39%
H: 2.0%
C: 1.94%
Newcourt Shareholders Approve Psyence Bioscience Deal … – DealFlow's SPAC News
Published: 2024-01-19 (Crawled : 14:30) - spacfeed.com
PB A | $59.69 0.51% 0.0% 400K
|
Finance
|
| O: 0.39%
H: 2.0%
C: 1.94%
bioscience spac deal
Regulatory and Corporate Approvals and Interim Covenants in Latin … – Latin Lawyer
Published: 2024-01-05 (Crawled : 14:30) - spacfeed.com
CPT 4 | $95.29 -0.03% 0.8% 560K
|
Finance
|
| O: -0.81%
H: 1.72%
C: 1.21%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.